November 2016 edition

​Our November edition is available to read now. The issue features companies and insight articles focused on nucleic-acid-based drugs, CNS and recent M&A activity in the pharma and biotech industry.

Go to the profile of Raveena Bhambra
Nov 01, 2016

Read the newly released November edition of BioPharma Dealmakers.

Browse through the companies looking for partnerships in CNS and nucleic-acid-based drugs.


Arcturus Therapeutics

Astex Pharmaceuticals


Cognition Therapeutics







Voyager Therapeutics

Aligning to these company profiles are our November in-depth feature articles that explore focus on the dealmaking activity within CNS, Pharma M&As and Nucleic-acid-based drugs.

Dealmaking and differentiation in migraine’s big new market

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.